|
||
|
The Journal of Nurse Practitioners
|
Jane Kapustin, PhD, CRNP - Figure 16
Management of Hyperglycemia in T2DM: Comorbidities: Liver dysfunction
Although liver dysfunction is another consideration (Figure 16), most of the drugs in Figures 4–6 have not been tested in patients with severe liver disease. Although pioglitazone has been shown to help with fatty liver syndrome, insulin is the best option in patients with severe liver disease and given any concern about moderate-to-severe liver dysfunction, the recommendation is to use insulin.[2] Kapustin J. J Nurse Pract. 2014; 00:00 – 00
References
[2]
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364-1379.